This Article Full Text Full Text (PDF) Data Supplement Data Supplement All Versions of this Article: 25/10/2170    most recent 01.ATV.0000181761.16341.2bv1 Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Abidi, P. Articles by Liu, J. Search for Related Content PubMed PubMed Citation Articles by Abidi, P. Articles by Liu, J. Related Collections Lipid and lipoprotein metabolism

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:2170.)
© 2005 American Heart Association, Inc.

Atherosclerosis and Lipoproteins

Extracellular Signal-Regulated Kinase–Dependent Stabilization of Hepatic Low-Density Lipoprotein Receptor mRNA by Herbal Medicine Berberine

Parveen Abidi; Yue Zhou; Jian-Dong Jiang; Jingwen Liu

From the VA Palo Alto Health Care System (P.A., Y.Z., J.L.), Palo Alto, Calif; and Institute of Medicinal Biotechnology (J.-D.J.), Chinese Academy of Medical Sciences, Beijing, China.

Correspondence to Jingwen Liu, PhD, VA Palo Alto Health Care System, 3801 Miranda Ave, Palo Alto, CA 94304. E-mail Jingwen.Liu{at}med.va.gov

Objective— Our recent studies identified berberine (BBR) as a novel cholesterol-lowering drug that upregulates low-density lipoprotein (LDL) receptor expression through mRNA stabilization. Here, we investigated mechanisms underlying regulatory effects of BBR on LDL receptor (LDLR) messenger.

Methods and Results— We show that the extracellular signal-regulated kinase (ERK) signaling pathway is used primarily by BBR to attenuate the decay of LDLR mRNA in HepG2 cells. Using different reporter constructs, we demonstrate that BBR affects LDLR mRNA stability entirely through 3' untranslated region (UTR) in an ERK-dependent manner, and this stabilizing effect is more prominent in liver-derived cells than nonhepatic cell lines. In contrast to BBR, the mRNA stabilizing effect of bile acid chenodeoxycholic acid is mediated through the LDLR coding sequence, whereas the 5'UTR, 3'UTR, and the coding sequence of LDLR mRNA are all implicated in the action of phorbol 12-myristate 13-acetate. By performing UV cross-linking and SDS-PAGE, we identify 2 cytoplasmic proteins of 52 and 42 kDa that specifically bind to the LDLR 3'UTR in BBR-inducible and ERK-dependent manners.

Conclusions— These new findings demonstrate that the BBR-induced stabilization of LDLR mRNA is mediated by the ERK signaling pathway through interactions of cis-regulatory sequences of 3'UTR and mRNA binding proteins that are downstream effectors of this signaling cascade.

Our recent studies identified berberine (BBR) as a novel cholesterol-lowering drug that upregulates low-density lipoprotein (LDL) receptor expression through mRNA stabilization. Here, we investigated mechanisms underlying regulatory effects of BBR on LDL receptor (LDLR) messenger. These new findings demonstrate that the BBR-induced stabilization of LDLR mRNA is mediated by the ERK signaling pathway through interactions of cis-regulatory sequences of 3'UTR and mRNA binding proteins that are downstream effectors of this signaling cascade.

Key Words: LDL receptor • berberine • mRNA stability • extracellular signal-regulated kinase • 3' untranslated region

This article has been cited by other articles:

				B. Fan, S. Ikuyama, J.-Q. Gu, P. Wei, J.-i. Oyama, T. Inoguchi, and J. Nishimura Oleic acid-induced ADRP expression requires both AP-1 and PPAR response elements, and is reduced by Pycnogenol through mRNA degradation in NMuLi liver cells Am J Physiol Endocrinol Metab, July 1, 2009; 297(1): E112 - E123. [Abstract] [Full Text] [PDF]

				H. Li, W. Chen, Y. Zhou, P. Abidi, O. Sharpe, W. H. Robinson, F. B. Kraemer, and J. Liu Identification of mRNA binding proteins that regulate the stability of LDL receptor mRNA through AU-rich elements J. Lipid Res., May 1, 2009; 50(5): 820 - 831. [Abstract] [Full Text] [PDF]

				H. W. Jeong, K. C. Hsu, J.-W. Lee, M. Ham, J. Y. Huh, H. J. Shin, W. S. Kim, and J. B. Kim Berberine suppresses proinflammatory responses through AMPK activation in macrophages Am J Physiol Endocrinol Metab, April 1, 2009; 296(4): E955 - E964. [Abstract] [Full Text] [PDF]

				N. B. Vargas, B. Y. Brewer, T. B. Rogers, and G. M. Wilson Protein kinase C activation stabilizes LDL receptor mRNA via the JNK pathway in HepG2 cells J. Lipid Res., March 1, 2009; 50(3): 386 - 397. [Abstract] [Full Text] [PDF]

				P. Abidi, W. Chen, F. B. Kraemer, H. Li, and J. Liu The medicinal plant goldenseal is a natural LDL-lowering agent with multiple bioactive components and new action mechanisms J. Lipid Res., October 1, 2006; 47(10): 2134 - 2147. [Abstract] [Full Text] [PDF]

				G. Muller, R. A. Catar, B. Niemann, M. Barton, L. Knels, M. Wendel, and H. Morawietz Upregulation of endothelin receptor B in human endothelial cells by low-density lipoproteins. Experimental Biology and Medicine, June 1, 2006; 231(6): 766 - 771. [Abstract] [Full Text] [PDF]

				J.-M. Brusq, N. Ancellin, P. Grondin, R. Guillard, S. Martin, Y. Saintillan, and M. Issandou Inhibition of lipid synthesis through activation of AMP kinase: an additional mechanism for the hypolipidemic effects of berberine J. Lipid Res., June 1, 2006; 47(6): 1281 - 1288. [Abstract] [Full Text] [PDF]